Caricamento...
Efficacy and safety of biosimilar filgrastim in primary and secondary prevention of febrile neutropenia
Neutropenia and febrile neutropenia (FN) are among the most common side effects/complications of chemotherapy. The aim of the present study was to evaluate the practice of the use of biosimilar filgrastim in the primary and secondary prevention of FN, and assess its efficacy and safety. A multi-cent...
Salvato in:
| Pubblicato in: | Biomed Rep |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
D.A. Spandidos
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5526162/ https://ncbi.nlm.nih.gov/pubmed/28804626 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/br.2017.938 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|